In this group of HGSC cases with known CCNE1 amplification, amplification largely appears conserved across metastatic sites of disease consistent with its presumed role as a truncal driver event, based on the occurrence of CCNE1 amplification in ovarian cancer precursor lesions. Here, CCNE1 is linked to ovarian cancer.